

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell migration (GO:0072678) | 8.33415953 |
| 2 | cytidine metabolic process (GO:0046087) | 5.81416995 |
| 3 | cytidine catabolic process (GO:0006216) | 5.81416995 |
| 4 | cytidine deamination (GO:0009972) | 5.81416995 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75086286 |
| 6 | cellular response to interleukin-15 (GO:0071350) | 5.47479400 |
| 7 | DNA deamination (GO:0045006) | 5.34056756 |
| 8 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.29178070 |
| 9 | response to interleukin-15 (GO:0070672) | 5.20064620 |
| 10 | negative regulation of type 2 immune response (GO:0002829) | 5.19186350 |
| 11 | positive regulation of T cell chemotaxis (GO:0010820) | 5.06603893 |
| 12 | regulation of T cell chemotaxis (GO:0010819) | 5.06603893 |
| 13 | lymphocyte chemotaxis (GO:0048247) | 5.02896333 |
| 14 | regulation of B cell differentiation (GO:0045577) | 5.02878716 |
| 15 | positive thymic T cell selection (GO:0045059) | 4.91321148 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.87325002 |
| 17 | positive regulation of B cell differentiation (GO:0045579) | 4.84485843 |
| 18 | lymphocyte migration (GO:0072676) | 4.81210483 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.78864390 |
| 20 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.76132777 |
| 21 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.71157897 |
| 22 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.56269703 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.53785904 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51392963 |
| 25 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.51327512 |
| 26 | negative regulation of T cell apoptotic process (GO:0070233) | 4.48882188 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.47450257 |
| 28 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.39796802 |
| 29 | negative thymic T cell selection (GO:0045060) | 4.38050080 |
| 30 | positive regulation of granulocyte differentiation (GO:0030854) | 4.36913347 |
| 31 | positive T cell selection (GO:0043368) | 4.33328019 |
| 32 | thymic T cell selection (GO:0045061) | 4.29397458 |
| 33 | negative T cell selection (GO:0043383) | 4.29389406 |
| 34 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28312041 |
| 35 | positive regulation of T cell migration (GO:2000406) | 4.22613239 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21996542 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 4.17786071 |
| 38 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.11854664 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.95963866 |
| 40 | regulation of T-helper 1 type immune response (GO:0002825) | 3.88653825 |
| 41 | regulation of cellular extravasation (GO:0002691) | 3.74651100 |
| 42 | T cell selection (GO:0045058) | 3.73878095 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 3.72504563 |
| 44 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.71128252 |
| 45 | positive regulation of lymphocyte migration (GO:2000403) | 3.70100137 |
| 46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.68385124 |
| 47 | regulation of T cell migration (GO:2000404) | 3.67632834 |
| 48 | cytolysis (GO:0019835) | 3.66989400 |
| 49 | response to interferon-beta (GO:0035456) | 3.65044533 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 3.63672237 |
| 51 | positive regulation of tolerance induction (GO:0002645) | 3.59393783 |
| 52 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57759195 |
| 53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.57258612 |
| 54 | negative regulation of viral genome replication (GO:0045071) | 3.56214376 |
| 55 | dendritic cell chemotaxis (GO:0002407) | 3.55826262 |
| 56 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.50121009 |
| 57 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.47971757 |
| 58 | positive regulation of defense response to virus by host (GO:0002230) | 3.47433182 |
| 59 | T cell receptor signaling pathway (GO:0050852) | 3.44567811 |
| 60 | intestinal cholesterol absorption (GO:0030299) | 3.42152601 |
| 61 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.41769994 |
| 62 | positive regulation of interleukin-2 production (GO:0032743) | 3.41140749 |
| 63 | activated T cell proliferation (GO:0050798) | 3.40460811 |
| 64 | mast cell activation (GO:0045576) | 3.39281626 |
| 65 | T cell costimulation (GO:0031295) | 3.39262386 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35171410 |
| 67 | lymphocyte costimulation (GO:0031294) | 3.34709443 |
| 68 | respiratory burst (GO:0045730) | 3.34163554 |
| 69 | mast cell degranulation (GO:0043303) | 3.32912096 |
| 70 | mast cell activation involved in immune response (GO:0002279) | 3.32912096 |
| 71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.32734918 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.29519517 |
| 73 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.26626374 |
| 74 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.26292111 |
| 75 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.23395758 |
| 76 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.22714905 |
| 77 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.21775515 |
| 78 | response to type I interferon (GO:0034340) | 3.20848807 |
| 79 | regulation of alpha-beta T cell activation (GO:0046634) | 3.20241629 |
| 80 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.20195806 |
| 81 | Peyers patch development (GO:0048541) | 3.20195806 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 3.19157601 |
| 83 | type I interferon signaling pathway (GO:0060337) | 3.19117139 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.19117139 |
| 85 | B cell mediated immunity (GO:0019724) | 3.14524628 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.12336570 |
| 87 | regulation of granulocyte differentiation (GO:0030852) | 3.09937829 |
| 88 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09806835 |
| 89 | negative regulation of cell killing (GO:0031342) | 3.09806835 |
| 90 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09734876 |
| 91 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05321490 |
| 92 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05321490 |
| 93 | regulation of type 2 immune response (GO:0002828) | 3.04163130 |
| 94 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.03513873 |
| 95 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.00259171 |
| 96 | T-helper cell differentiation (GO:0042093) | 3.00259171 |
| 97 | regulation of lymphocyte migration (GO:2000401) | 2.98021235 |
| 98 | chemokine-mediated signaling pathway (GO:0070098) | 2.97235594 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.96498249 |
| 100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94960187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.15228595 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.88083708 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.15911882 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.02182099 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.49707056 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.61731529 |
| 7 | MYB_26560356_Chip-Seq_TH2_Human | 3.60435712 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45139174 |
| 9 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.37832517 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.18057479 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.98663443 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.89811525 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76425723 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.64540772 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.60415560 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.54937177 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.46492906 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.40989468 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.38983544 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35180763 |
| 21 | MAF_26560356_Chip-Seq_TH2_Human | 2.35118257 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.33373187 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22486004 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.21987247 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10647693 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 2.02100395 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99972060 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.99386222 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98565340 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96351972 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93365399 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.92882617 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.92503580 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87912324 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83766784 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.81917452 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78053258 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73864243 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.73692480 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73118430 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66232941 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54600547 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46596733 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45455938 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43023851 |
| 46 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40730154 |
| 47 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38041780 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36741157 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29136867 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.27648363 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.25364938 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23073686 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21185939 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19963197 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18391583 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17593178 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15303906 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13350065 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11559611 |
| 60 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10994177 |
| 61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08900417 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08658433 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06609986 |
| 64 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.05891330 |
| 65 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05674584 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04628852 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03659843 |
| 68 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01566638 |
| 69 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01032591 |
| 70 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00128901 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93098421 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90036467 |
| 73 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89045880 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88635847 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88310372 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87325112 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87163487 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86429330 |
| 79 | GATA3_26560356_Chip-Seq_TH1_Human | 0.86416458 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86259980 |
| 81 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85903337 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84630763 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84513156 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83906472 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83737506 |
| 86 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83601689 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83382527 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78782828 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77940843 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77771960 |
| 91 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.77536089 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76481954 |
| 93 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.75429823 |
| 94 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74974426 |
| 95 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74483824 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74318771 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73397291 |
| 98 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.72582816 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71873699 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71635956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.53957059 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.81756275 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.44859770 |
| 4 | MP0009785_altered_susceptibility_to | 3.58184107 |
| 5 | MP0003045_fibrosis | 3.45684594 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.19913877 |
| 7 | MP0001800_abnormal_humoral_immune | 3.12563421 |
| 8 | MP0003436_decreased_susceptibility_to | 3.04126397 |
| 9 | MP0005025_abnormal_response_to | 2.87019149 |
| 10 | MP0005387_immune_system_phenotype | 2.84659710 |
| 11 | MP0001790_abnormal_immune_system | 2.84659710 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.83102852 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.74675464 |
| 14 | MP0001819_abnormal_immune_cell | 2.72672598 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.70105526 |
| 16 | MP0002723_abnormal_immune_serum | 2.61586489 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.45731514 |
| 18 | MP0003866_abnormal_defecation | 2.38693345 |
| 19 | MP0002405_respiratory_system_inflammati | 2.38132939 |
| 20 | MP0000685_abnormal_immune_system | 2.37745107 |
| 21 | MP0002398_abnormal_bone_marrow | 2.35694255 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.35435665 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.35047927 |
| 24 | MP0006082_CNS_inflammation | 2.23557910 |
| 25 | MP0002006_tumorigenesis | 2.23073410 |
| 26 | MP0000716_abnormal_immune_system | 2.18920510 |
| 27 | MP0002419_abnormal_innate_immunity | 2.18912094 |
| 28 | MP0004381_abnormal_hair_follicle | 2.17666238 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.16224774 |
| 30 | MP0003448_altered_tumor_morphology | 2.08230378 |
| 31 | MP0002722_abnormal_immune_system | 2.06122604 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.90524875 |
| 33 | MP0001873_stomach_inflammation | 1.84667034 |
| 34 | MP0005166_decreased_susceptibility_to | 1.79887418 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.77062319 |
| 36 | MP0002429_abnormal_blood_cell | 1.70753682 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.66416590 |
| 38 | MP0003724_increased_susceptibility_to | 1.65126242 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.64254782 |
| 40 | MP0004947_skin_inflammation | 1.63155229 |
| 41 | MP0005075_abnormal_melanosome_morpholog | 1.43718150 |
| 42 | MP0008469_abnormal_protein_level | 1.20376159 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.18757127 |
| 44 | MP0003075_altered_response_to | 1.17279452 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.15506567 |
| 46 | MP0002168_other_aberrant_phenotype | 1.15462662 |
| 47 | MP0002019_abnormal_tumor_incidence | 1.12418700 |
| 48 | MP0000604_amyloidosis | 1.07892612 |
| 49 | MP0005310_abnormal_salivary_gland | 1.06515955 |
| 50 | MP0009278_abnormal_bone_marrow | 1.06436028 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.06427972 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.05327697 |
| 53 | MP0002933_joint_inflammation | 1.00143358 |
| 54 | MP0002998_abnormal_bone_remodeling | 0.94955883 |
| 55 | MP0008877_abnormal_DNA_methylation | 0.94141858 |
| 56 | MP0000858_altered_metastatic_potential | 0.93533086 |
| 57 | MP0009763_increased_sensitivity_to | 0.90156001 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.89623431 |
| 59 | MP0003172_abnormal_lysosome_physiology | 0.83557191 |
| 60 | MP0001542_abnormal_bone_strength | 0.80896871 |
| 61 | MP0004883_abnormal_blood_vessel | 0.78377452 |
| 62 | MP0001853_heart_inflammation | 0.75444581 |
| 63 | MP0003329_amyloid_beta_deposits | 0.75170808 |
| 64 | MP0008007_abnormal_cellular_replicative | 0.74442985 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.74188371 |
| 66 | MP0001188_hyperpigmentation | 0.72745538 |
| 67 | MP0002132_abnormal_respiratory_system | 0.71001662 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.69379122 |
| 69 | MP0003690_abnormal_glial_cell | 0.68130624 |
| 70 | MP0009840_abnormal_foam_cell | 0.64715540 |
| 71 | MP0009764_decreased_sensitivity_to | 0.64498237 |
| 72 | MP0010307_abnormal_tumor_latency | 0.61261700 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61007953 |
| 74 | MP0003795_abnormal_bone_structure | 0.60963742 |
| 75 | MP0008873_increased_physiological_sensi | 0.60302002 |
| 76 | MP0005084_abnormal_gallbladder_morpholo | 0.59880160 |
| 77 | MP0001545_abnormal_hematopoietic_system | 0.59410639 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 0.59410639 |
| 79 | MP0003786_premature_aging | 0.57709742 |
| 80 | MP0000920_abnormal_myelination | 0.57564584 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.57077492 |
| 82 | MP0001851_eye_inflammation | 0.56892314 |
| 83 | MP0001666_abnormal_nutrient_absorption | 0.55676522 |
| 84 | MP0005164_abnormal_response_to | 0.52634432 |
| 85 | MP0002693_abnormal_pancreas_physiology | 0.52526763 |
| 86 | MP0002876_abnormal_thyroid_physiology | 0.51347402 |
| 87 | MP0000343_altered_response_to | 0.51324797 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.50969296 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.50868562 |
| 90 | MP0010094_abnormal_chromosome_stability | 0.49868623 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.49430238 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.48695861 |
| 93 | MP0001919_abnormal_reproductive_system | 0.48192345 |
| 94 | MP0002083_premature_death | 0.45942912 |
| 95 | MP0001663_abnormal_digestive_system | 0.45618625 |
| 96 | MP0002653_abnormal_ependyma_morphology | 0.43923278 |
| 97 | MP0001502_abnormal_circadian_rhythm | 0.42614049 |
| 98 | MP0005410_abnormal_fertilization | 0.41478550 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.41336339 |
| 100 | MP0001905_abnormal_dopamine_level | 0.40569416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.03604996 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.13044373 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 4.82999313 |
| 4 | Autoimmune hemolytic anemia (HP:0001890) | 4.81985541 |
| 5 | Abnormality of T cells (HP:0002843) | 4.78457099 |
| 6 | Recurrent viral infections (HP:0004429) | 4.64856412 |
| 7 | Hypoproteinemia (HP:0003075) | 4.63896730 |
| 8 | Aplastic anemia (HP:0001915) | 4.62628291 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.60810444 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57389798 |
| 11 | Stomatitis (HP:0010280) | 4.56802265 |
| 12 | IgG deficiency (HP:0004315) | 4.52576102 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 4.52195165 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.52195165 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.47963458 |
| 16 | Abnormality of macrophages (HP:0004311) | 4.40554100 |
| 17 | Panhypogammaglobulinemia (HP:0003139) | 4.40531925 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.37741533 |
| 19 | Thyroiditis (HP:0100646) | 4.33985505 |
| 20 | Abnormality of eosinophils (HP:0001879) | 4.32555607 |
| 21 | Hemiplegia (HP:0002301) | 4.21520637 |
| 22 | Hypoplasia of the thymus (HP:0000778) | 4.21328620 |
| 23 | Encephalitis (HP:0002383) | 4.11492054 |
| 24 | Meningitis (HP:0001287) | 4.11077964 |
| 25 | Eosinophilia (HP:0001880) | 4.03404141 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 3.84685527 |
| 27 | B lymphocytopenia (HP:0010976) | 3.80791080 |
| 28 | Chronic diarrhea (HP:0002028) | 3.80742083 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.79964992 |
| 30 | Leukocytosis (HP:0001974) | 3.76588620 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 3.76004089 |
| 32 | Combined immunodeficiency (HP:0005387) | 3.75165764 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.72064764 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65550480 |
| 35 | Granulocytopenia (HP:0001913) | 3.58381059 |
| 36 | Eczematoid dermatitis (HP:0000976) | 3.37598295 |
| 37 | Myositis (HP:0100614) | 3.29595375 |
| 38 | Abnormality of the prostate (HP:0008775) | 3.26303914 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 3.19619887 |
| 40 | Recurrent abscess formation (HP:0002722) | 3.16627931 |
| 41 | Increased IgM level (HP:0003496) | 3.11733231 |
| 42 | Renal cortical cysts (HP:0000803) | 3.06150630 |
| 43 | Obstructive lung disease (HP:0006536) | 3.00612012 |
| 44 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00612012 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.97544760 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.90985566 |
| 47 | Abnormality of the columella (HP:0009929) | 2.82664713 |
| 48 | Recurrent skin infections (HP:0001581) | 2.77116979 |
| 49 | Lymphoma (HP:0002665) | 2.68748278 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.67080489 |
| 51 | Orchitis (HP:0100796) | 2.58296551 |
| 52 | Retrobulbar optic neuritis (HP:0100654) | 2.53777274 |
| 53 | Optic neuritis (HP:0100653) | 2.53777274 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.50108867 |
| 55 | Lymphopenia (HP:0001888) | 2.49661017 |
| 56 | Abnormality of oral frenula (HP:0000190) | 2.46517247 |
| 57 | Vasculitis (HP:0002633) | 2.40555180 |
| 58 | Recurrent bacterial skin infections (HP:0005406) | 2.37108298 |
| 59 | Pulmonary infiltrates (HP:0002113) | 2.36187438 |
| 60 | Visual hallucinations (HP:0002367) | 2.28527217 |
| 61 | Acute lymphatic leukemia (HP:0006721) | 2.27598448 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21420682 |
| 63 | Increased IgE level (HP:0003212) | 2.20643591 |
| 64 | Prostate neoplasm (HP:0100787) | 2.20572412 |
| 65 | Chest pain (HP:0100749) | 2.17902206 |
| 66 | Hypochromic microcytic anemia (HP:0004840) | 2.17713134 |
| 67 | Hemoptysis (HP:0002105) | 2.15294291 |
| 68 | Acute hepatic failure (HP:0006554) | 2.14076265 |
| 69 | Hypergammaglobulinemia (HP:0010702) | 2.11097431 |
| 70 | Pustule (HP:0200039) | 2.11020266 |
| 71 | Hypoalbuminemia (HP:0003073) | 2.10169187 |
| 72 | Abnormal albumin level (HP:0012116) | 2.10169187 |
| 73 | Increased serum ferritin (HP:0003281) | 2.09493734 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08130642 |
| 75 | Skin rash (HP:0000988) | 2.04158878 |
| 76 | Clumsiness (HP:0002312) | 2.02482697 |
| 77 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97422229 |
| 78 | Papilledema (HP:0001085) | 1.97272080 |
| 79 | Keratoconjunctivitis (HP:0001096) | 1.96545991 |
| 80 | Papilloma (HP:0012740) | 1.96146543 |
| 81 | Verrucae (HP:0200043) | 1.96146543 |
| 82 | Gingivitis (HP:0000230) | 1.95646788 |
| 83 | Pulmonary embolism (HP:0002204) | 1.95565899 |
| 84 | Inflammation of the large intestine (HP:0002037) | 1.94728446 |
| 85 | Joint swelling (HP:0001386) | 1.94279974 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 1.91534883 |
| 87 | Failure to thrive in infancy (HP:0001531) | 1.90867878 |
| 88 | Tetraplegia (HP:0002445) | 1.90686749 |
| 89 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88267190 |
| 90 | Microcytic anemia (HP:0001935) | 1.86007344 |
| 91 | Pancytopenia (HP:0001876) | 1.85208415 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 1.83365920 |
| 93 | Abnormality of male internal genitalia (HP:0000022) | 1.82688435 |
| 94 | Testicular atrophy (HP:0000029) | 1.82631132 |
| 95 | IgM deficiency (HP:0002850) | 1.81418037 |
| 96 | Urticaria (HP:0001025) | 1.79054592 |
| 97 | Arterial thrombosis (HP:0004420) | 1.78675145 |
| 98 | Increased CSF protein (HP:0002922) | 1.77930813 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 1.76030329 |
| 100 | Increased muscle lipid content (HP:0009058) | 1.75841587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.28178474 |
| 2 | BCKDK | 5.24665085 |
| 3 | TXK | 5.23171570 |
| 4 | ITK | 3.64387885 |
| 5 | KDR | 3.00408725 |
| 6 | FES | 2.62273870 |
| 7 | ZAP70 | 2.58737654 |
| 8 | PIK3CG | 2.29715020 |
| 9 | TESK2 | 2.17489887 |
| 10 | NLK | 2.10766075 |
| 11 | SYK | 2.09726856 |
| 12 | BTK | 2.05166354 |
| 13 | KIT | 1.93532081 |
| 14 | GRK6 | 1.87627230 |
| 15 | MAPKAPK3 | 1.62261269 |
| 16 | CSK | 1.61957326 |
| 17 | FLT3 | 1.61486476 |
| 18 | TLK1 | 1.60246844 |
| 19 | ERN1 | 1.59462566 |
| 20 | PRKCQ | 1.58691453 |
| 21 | LCK | 1.57684510 |
| 22 | JAK3 | 1.51342305 |
| 23 | TEC | 1.42851468 |
| 24 | EPHA3 | 1.42153016 |
| 25 | MAP2K7 | 1.41211582 |
| 26 | CSNK1A1L | 1.38390420 |
| 27 | TYK2 | 1.37533445 |
| 28 | MARK3 | 1.35790715 |
| 29 | TAOK3 | 1.33584492 |
| 30 | JAK2 | 1.26975795 |
| 31 | CSNK1G3 | 1.26165131 |
| 32 | CSF1R | 1.18417180 |
| 33 | MAP3K11 | 1.13511624 |
| 34 | EIF2AK3 | 1.12516472 |
| 35 | PINK1 | 1.09829009 |
| 36 | HCK | 1.07837762 |
| 37 | IKBKB | 1.04048803 |
| 38 | RIPK4 | 1.03379519 |
| 39 | LYN | 1.03329773 |
| 40 | JAK1 | 1.02637356 |
| 41 | IKBKE | 1.00198391 |
| 42 | MAP3K1 | 0.98751914 |
| 43 | IRAK4 | 0.92109172 |
| 44 | BLK | 0.89626859 |
| 45 | PRPF4B | 0.89551911 |
| 46 | CAMKK2 | 0.86762299 |
| 47 | EPHB1 | 0.85488146 |
| 48 | FGFR4 | 0.84412907 |
| 49 | NME2 | 0.83448338 |
| 50 | CSNK1G1 | 0.81462074 |
| 51 | FGFR3 | 0.79832962 |
| 52 | HIPK2 | 0.79591455 |
| 53 | MAPK11 | 0.76348740 |
| 54 | CSNK1G2 | 0.74885851 |
| 55 | TNK2 | 0.70391478 |
| 56 | FRK | 0.68791078 |
| 57 | MAP3K14 | 0.65594440 |
| 58 | TBK1 | 0.64605226 |
| 59 | MAPK12 | 0.62846089 |
| 60 | RPS6KA4 | 0.59633974 |
| 61 | FYN | 0.57635105 |
| 62 | PIM1 | 0.55446493 |
| 63 | TGFBR2 | 0.55353316 |
| 64 | TGFBR1 | 0.55281268 |
| 65 | ALK | 0.52975293 |
| 66 | BMPR2 | 0.52957650 |
| 67 | RPS6KB1 | 0.52080635 |
| 68 | CSNK1A1 | 0.47349527 |
| 69 | PDK1 | 0.47129496 |
| 70 | RPS6KA5 | 0.44226469 |
| 71 | ZAK | 0.42346941 |
| 72 | DAPK1 | 0.41754556 |
| 73 | PRKCH | 0.40465414 |
| 74 | MAPK3 | 0.39553135 |
| 75 | MAPKAPK2 | 0.39315747 |
| 76 | NEK2 | 0.38617922 |
| 77 | RET | 0.36211907 |
| 78 | IRAK1 | 0.35131328 |
| 79 | MAP3K5 | 0.31632292 |
| 80 | MATK | 0.30925510 |
| 81 | MAP2K3 | 0.29584773 |
| 82 | IGF1R | 0.28384785 |
| 83 | MAPK9 | 0.27098502 |
| 84 | ADRBK2 | 0.27026078 |
| 85 | CAMKK1 | 0.25046010 |
| 86 | STK10 | 0.22854556 |
| 87 | INSR | 0.20151408 |
| 88 | GSK3A | 0.20020717 |
| 89 | CDK12 | 0.19719746 |
| 90 | CSNK2A1 | 0.18630855 |
| 91 | AURKA | 0.17667816 |
| 92 | GRK1 | 0.16861035 |
| 93 | CSNK2A2 | 0.16672559 |
| 94 | PRKCD | 0.16293647 |
| 95 | MAP3K3 | 0.16287590 |
| 96 | TIE1 | 0.14723977 |
| 97 | CSNK1D | 0.14062071 |
| 98 | RPS6KA1 | 0.12523332 |
| 99 | EGFR | 0.12417869 |
| 100 | CHUK | 0.11216733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.32408584 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 4.39638659 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.22603507 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.19289499 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.41054671 |
| 6 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.89745180 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.77109603 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.76295701 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.60049571 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.38079758 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04674866 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.96213915 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79580604 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 1.76561441 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.75535127 |
| 16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62154581 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.61067480 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.53631256 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52813876 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47629489 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38851253 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37463372 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36153482 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31724473 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29959487 |
| 26 | Phototransduction_Homo sapiens_hsa04744 | 1.24701993 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12319043 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11086609 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.10542085 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09496770 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.06699952 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03978522 |
| 33 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.03799687 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00554628 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99507414 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99327351 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.99066014 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98532991 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96960851 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96735490 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.91917916 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.89428647 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.88936371 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87643631 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 0.84216305 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.83173371 |
| 47 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82398256 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81687571 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81550234 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78175162 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.76925253 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76051748 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72686189 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70890983 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69866011 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66013319 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.64056718 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58045390 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.56320351 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53957743 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.53627237 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53484690 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52095471 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51087183 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51054179 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.50814325 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48552187 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.47004509 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.44894589 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.43595132 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40512917 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40230392 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.38283748 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36692861 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.36318662 |
| 76 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.32885645 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.32838993 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29730356 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29009949 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28958778 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27501169 |
| 82 | Glioma_Homo sapiens_hsa05214 | 0.26801610 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.26165486 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24416652 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24243538 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22972055 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22796638 |
| 88 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22696298 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.22602375 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.21615566 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20614008 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20286025 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.19602079 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.17329708 |
| 95 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.16139601 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.14397513 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.13651756 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12911786 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.12285787 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.11720433 |

